Interestingly, T cell influx of peripherally expanded T cells into tumor sites was observed in responding patients, and general enrichment of IDO- and PD-L1-specific clones after treatment was documented, suggesting a potential of this immunomodulating approach (103). Here, CD274 is linked to neoplasm.